Toth Financial Advisory’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-46
Closed -$880 738
2024
Q3
$880 Hold
46
﹤0.01% 675
2024
Q2
$953 Hold
46
﹤0.01% 698
2024
Q1
$865 Hold
46
﹤0.01% 688
2023
Q4
$664 Sell
46
-3
-6% -$41 ﹤0.01% 701
2023
Q3
$851 Buy
49
+7
+17% +$146 ﹤0.01% 720
2023
Q2
$875 Hold
42
﹤0.01% 735
2023
Q1
$988 Hold
42
﹤0.01% 756
2022
Q4
$1.17K Hold
42
﹤0.01% 655
2022
Q3
$1K Hold
42
﹤0.01% 709
2022
Q2
$1K Hold
42
﹤0.01% 658
2022
Q1
$1K Hold
42
﹤0.01% 676
2021
Q4
$1K Hold
42
﹤0.01% 706
2021
Q3
$1K Hold
42
﹤0.01% 720
2021
Q2
$1K Buy
+42
New +$1.38K ﹤0.01% 657

Other funds holding OGN

Toth Financial Advisory's OGN Position: Q4 2024 in Review

Toth Financial Advisory sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 46 shares — an estimated $880 sold.

Toth Financial Advisory first reported a position in OGN in Q2 2021 and held it in 14 quarters. The position peaked at $1.17K in Q4 2022. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Toth Financial Advisory reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Toth Financial Advisory sold 46 Organon & Co shares in Q4 2024, an estimated $880.
  • Toth Financial Advisory first reported a position in Organon & Co in Q2 2021 and held it in 14 quarters.
  • Toth Financial Advisory's Organon & Co position peaked at $1.17K in Q4 2022.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Toth Financial Advisory's 13F filing for Q4 2024, filed 21 Jan 2025.